Need help finding what you are looking for?
Contact Us
PUBLISHER: Polaris Market Research | PRODUCT CODE: 1463112
PUBLISHER: Polaris Market Research | PRODUCT CODE: 1463112
Trachoma Treatment Market Share, Size, Trends, Industry Analysis Report, By Route of Administration (Oral and Topical); By Drug Class; By Region; Segment Forecast, 2024 - 2032
PUBLISHED:
PAGES: 119 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
The global trachoma treatment market size is expected to reach USD 924.43 million by 2032, according to a new study by Polaris Market Research. The report "Trachoma Treatment Market Share, Size, Trends, Industry Analysis Report, By Route of Administration (Oral and Topical); By Drug Class; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The rapid increase in the prevalence of trachoma and its proliferation among private and public healthcare organizations to raise awareness about trachoma and its treatment options among the general public are prominent factors driving the market growth. For instance, in January 2024, the number of people living in districts with a high prevalence of active trachoma was estimated at around 116 million in 2023, and over 1.5 million people required surgery for trichiasis.
In addition, a growing number of favorable regulatory policies and incentive programs promoting the development of new trachoma treatments to control the spread of preventable blindness worldwide, further boosting market growth. For instance, in February 2024, The Federal government announced the launch of its new program to eliminate diseases, including trachoma, malaria, filariasis, onchocerciasis, and goehelminthiasis
Furthermore, as trachoma is most prevalent is under-developed or developing economies of MEA and APAC region, thereby the need for significant improvements in healthcare infrastructure is growing and encouraging global healthcare companies to expand their market presence in these emerging and untapped markets. With companies and governments increasingly investing in healthcare infrastructure development and making healthcare services easily accessible to a larger patient population, the demand for effective trachoma treatment options will boost drastically. For instance, according to the International Trade Administration, in January 2024, the Malaysian government continued to strengthen its healthcare sector, increasing the national budget for healthcare to USD 7.9 million compared to USD 7.1 million in 2022.
The emergence of digital health technologies and telemedicine across the globe, which enables the remote diagnosis and treatment of trachoma, is presenting a lucrative opportunity for companies providing trachoma treatment solutions. Also, companies focusing on the development of products for trachoma prevention including hygiene and sanitation solutions and new drugs that are easy to administer and affordable as compared to conventional solutions, are likely to gain a competitive edge in the market.
Trachoma Treatment Market Report Highlights
Oral segment accounted for a noteworthy share, which is attributed to its characteristics, including systemic coverage, reduced contamination risk, and east administration
The macrolides segment held a significant share due to its affordability, reduced resistance, easy availability, and shorter treatment time
North America dominated the global market on account of well-established healthcare infrastructure and rising R&D activities for the development of new solutions
The key market players include Allergan Inc., Eli Lilly and Company, Bayer AG, Bausch Health Companies, Cipla, Novartis AG, Arbor Pharmaceuticals, and AbbVie
Polaris Market Research has segmented the trachoma treatment market report based on route of administration, drug class, and region:
Trachoma Treatment, Route of Administration Outlook (Revenue - USD Million, 2019 - 2032)
- Oral
- Topical
Trachoma Treatment, Drug Class Outlook (Revenue - USD Million, 2019 - 2032)
- Macrolides
- Tetracycline
- Ophthalmic Anti-Infective
- Sulfonamides
Trachoma Treatment, Regional Outlook (Revenue - USD Million, 2019 - 2032)
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Netherlands
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Indonesia
- Malaysia
- Australia
- Rest of APAC
- Latin America
- Argentina
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- UAE
- Saudi Arabia
- Israel
- South Africa
- Rest of MEA
Product Code: PM4785
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Trachoma Treatment Market Insights
- 4.1. Trachoma Treatment Market - Industry Snapshot
- 4.2. Trachoma Treatment Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Increasing prevalence of trachoma and awareness about disease prevention to drive growth
- 4.2.1.2. Improvements in healthcare expenditure and advancements in treatments to boost market growth
- 4.2.2. Restraints and Challenges
- 4.2.2.1. High cost associated with treatment and lack of awareness
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTLE Analysis
- 4.5. Trachoma Treatment Industry trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global Trachoma Treatment Market, by Route of Administration
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Trachoma Treatment, by Route of Administration, 2019-2032 (USD Million)
- 5.3. Oral
- 5.3.1. Global Trachoma Treatment Market, by Oral, by Region, 2019-2032 (USD Million)
- 5.4. Topical
- 5.4.1. Global Trachoma Treatment Market, by Topical, by Region, 2019-2032 (USD Million)
6. Global Trachoma Treatment Market, by Drug Class
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
- 6.3. Macrolides
- 6.3.1. Global Trachoma Treatment Market, by Macrolides, by Region, 2019-2032 (USD Million)
- 6.4. Tetracycline
- 6.4.1. Global Trachoma Treatment Market, by Tetracycline, by Region, 2019-2032 (USD Million)
- 6.5. Ophthalmic Anti-infective
- 6.5.1. Global Trachoma Treatment Market, by Ophthalmic Anti-infective, by Region, 2019-2032 (USD Million)
- 6.6. Sulfonamides
- 6.6.1. Global Trachoma Treatment Market, by Sulfonamides, by Region, 2019-2032 (USD Million)
7. Global Trachoma Treatment Market, by Geography
- 7.1. Key findings
- 7.2. Introduction
- 7.2.1. Trachoma Treatment Market Assessment, By Geography, 2019-2032 (USD Million)
- 7.3. Trachoma Treatment Market - North America
- 7.3.1. North America: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
- 7.3.2. North America: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
- 7.3.3. Trachoma Treatment Market - U.S.
- 7.3.3.1. U.S.: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
- 7.3.3.2. U.S.: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
- 7.3.4. Trachoma Treatment Market - Canada
- 7.3.4.1. Canada: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
- 7.3.4.2. Canada: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
- 7.4. Trachoma Treatment Market - Europe
- 7.4.1. Europe: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
- 7.4.2. Europe: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
- 7.4.3. Trachoma Treatment Market - UK
- 7.4.3.1. UK: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
- 7.4.3.2. UK: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
- 7.4.4. Trachoma Treatment Market - France
- 7.4.4.1. France: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
- 7.4.4.2. France: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
- 7.4.5. Trachoma Treatment Market - Germany
- 7.4.5.1. Germany: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
- 7.4.5.2. Germany: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
- 7.4.6. Trachoma Treatment Market - Italy
- 7.4.6.1. Italy: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
- 7.4.6.2. Italy: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
- 7.4.7. Trachoma Treatment Market - Spain
- 7.4.7.1. Spain: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
- 7.4.7.2. Spain: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
- 7.4.8. Trachoma Treatment Market - Netherlands
- 7.4.8.1. Netherlands: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
- 7.4.8.2. Netherlands: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
- 7.4.9. Trachoma Treatment Market - Russia
- 7.4.9.1. Russia: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
- 7.4.9.2. Russia: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
- 7.5. Trachoma Treatment Market - Asia Pacific
- 7.5.1. Asia Pacific: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
- 7.5.2. Asia Pacific: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
- 7.5.3. Trachoma Treatment Market - China
- 7.5.3.1. China: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
- 7.5.3.2. China: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
- 7.5.4. Trachoma Treatment Market - India
- 7.5.4.1. India: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
- 7.5.4.2. India: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
- 7.5.5. Trachoma Treatment Market - Malaysia
- 7.5.5.1. Malaysia: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
- 7.5.5.2. Malaysia: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
- 7.5.6. Trachoma Treatment Market - Japan
- 7.5.6.1. Japan: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
- 7.5.6.2. Japan: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
- 7.5.7. Trachoma Treatment Market - Indonesia
- 7.5.7.1. Indonesia: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
- 7.5.7.2. Indonesia: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
- 7.5.8. Trachoma Treatment Market - South Korea
- 7.5.8.1. South Korea: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
- 7.5.8.2. South Korea: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
- 7.6. Trachoma Treatment Market - Middle East & Africa
- 7.6.1. Middle East & Africa: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
- 7.6.2. Middle East & Africa: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
- 7.6.3. Trachoma Treatment Market - Saudi Arabia
- 7.6.3.1. Saudi Arabia: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
- 7.6.3.2. Saudi Arabia: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
- 7.6.4. Trachoma Treatment Market - UAE
- 7.6.4.1. UAE: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
- 7.6.4.2. UAE: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
- 7.6.5. Trachoma Treatment Market - Israel
- 7.6.5.1. Israel: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
- 7.6.5.2. Israel: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
- 7.6.6. Trachoma Treatment Market - South Africa
- 7.6.6.1. South Africa: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
- 7.6.6.2. South Africa: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
- 7.7. Trachoma Treatment Market - Latin America
- 7.7.1. Latin America: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
- 7.7.2. Latin America: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
- 7.7.3. Trachoma Treatment Market - Mexico
- 7.7.3.1. Mexico: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
- 7.7.3.2. Mexico: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
- 7.7.4. Trachoma Treatment Market - Brazil
- 7.7.4.1. Brazil: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
- 7.7.4.2. Brazil: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
- 7.7.5. Trachoma Treatment Market - Argentina
- 7.7.5.1. Argentina: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
- 7.7.5.2. Argentina: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
8. Competitive Landscape
- 8.1. Expansion and Acquisition Analysis
- 8.1.1. Expansion
- 8.1.2. Acquisitions
- 8.2. Partnerships/Collaborations/Agreements/Exhibitions
9. Company Profiles
- 9.1. Abbott Laboratories
- 9.1.1. Company Overview
- 9.1.2. Financial Performance
- 9.1.3. Product Benchmarking
- 9.1.4. Recent Development
- 9.2. AbbVie Inc.
- 9.2.1. Company Overview
- 9.2.2. Financial Performance
- 9.2.3. Product Benchmarking
- 9.2.4. Recent Development
- 9.3. Allergan Inc
- 9.3.1. Company Overview
- 9.3.2. Financial Performance
- 9.3.3. Product Benchmarking
- 9.3.4. Recent Development
- 9.4. Arbor Pharmaceuticals Inc.
- 9.4.1. Company Overview
- 9.4.2. Financial Performance
- 9.4.3. Product Benchmarking
- 9.4.4. Recent Development
- 9.5. Bausch Health Companies Inc.
- 9.5.1. Company Overview
- 9.5.2. Financial Performance
- 9.5.3. Product Benchmarking
- 9.5.4. Recent Development
- 9.6. Bayer AG.
- 9.6.1. Company Overview
- 9.6.2. Financial Performance
- 9.6.3. Product Benchmarking
- 9.6.4. Recent Development
- 9.7. Cipla Inc
- 9.7.1. Company Overview
- 9.7.2. Financial Performance
- 9.7.3. Product Benchmarking
- 9.7.4. Recent Development
- 9.8. Eli Lilly and Company
- 9.8.1. Company Overview
- 9.8.2. Financial Performance
- 9.8.3. Product Benchmarking
- 9.8.4. Recent Development
- 9.9. F. Hoffmann-La Roche Ltd
- 9.9.1. Company Overview
- 9.9.2. Financial Performance
- 9.9.3. Product Benchmarking
- 9.9.4. Recent Development
- 9.10. Merck & Co. Inc.
- 9.10.1. Company Overview
- 9.10.2. Financial Performance
- 9.10.3. Product Benchmarking
- 9.10.4. Recent Development
- 9.11. Mylan NV
- 9.11.1. Company Overview
- 9.11.2. Financial Performance
- 9.11.3. Product Benchmarking
- 9.11.4. Recent Development
- 9.12. Novartis AG
- 9.12.1. Company Overview
- 9.12.2. Financial Performance
- 9.12.3. Product Benchmarking
- 9.12.4. Recent Development
- 9.13. Pfizer Inc.
- 9.13.1. Company Overview
- 9.13.2. Financial Performance
- 9.13.3. Product Benchmarking
- 9.13.4. Recent Development
- 9.14. Sanofi SA
- 9.14.1. Company Overview
- 9.14.2. Financial Performance
- 9.14.3. Product Benchmarking
- 9.14.4. Recent Development
Product Code: PM4785
List of Tables
- Table 1 Global Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
- Table 2 Global Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
- Table 3 Trachoma Treatment Market Assessment, By Geography, 2019-2032 (USD Million)
- Table 4 North America: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
- Table 5 North America: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
- Table 6 U.S.: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
- Table 7 U.S.: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
- Table 8 Canada: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
- Table 9 Canada: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
- Table 10 Europe: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
- Table 11 Europe: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
- Table 12 UK: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
- Table 13 UK: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
- Table 14 France: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
- Table 15 France: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
- Table 16 Germany: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
- Table 17 Germany: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
- Table 18 Italy: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
- Table 19 Italy: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
- Table 20 Spain: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
- Table 21 Spain: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
- Table 22 Netherlands: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
- Table 23 Netherlands: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
- Table 24 Russia: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
- Table 25 Russia: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
- Table 26 Asia Pacific: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
- Table 27 Asia Pacific: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
- Table 28 China: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
- Table 29 China: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
- Table 30 India: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
- Table 31 India: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
- Table 32 Malaysia: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
- Table 33 Malaysia: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
- Table 34 Japan: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
- Table 35 Japan: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
- Table 36 Indonesia: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
- Table 37 Indonesia: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
- Table 38 South Korea: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
- Table 39 South Korea: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
- Table 40 Middle East & Africa: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
- Table 41 Middle East & Africa: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
- Table 42 Saudi Arabia: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
- Table 43 Saudi Arabia: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
- Table 44 UAE: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
- Table 45 UAE: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
- Table 46 Israel: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
- Table 47 Israel: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
- Table 48 South Africa: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
- Table 49 South Africa: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
- Table 50 Latin America: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
- Table 51 Latin America: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
- Table 52 Mexico: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
- Table 53 Mexico: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
- Table 54 Brazil: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
- Table 55 Brazil: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
- Table 56 Argentina: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
- Table 57 Argentina: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
List of Figures
- Figure 1 Global Trachoma Treatment Market, 2019-2032 (USD Million)
- Figure 2 Integrated Ecosystem
- Figure 3 Research Methodology: Top-Down & Bottom-Up Approach
- Figure 4 Market by Geography
- Figure 5 Porter's Five Forces
- Figure 6 Market by Drug Class
- Figure 7 Global Trachoma Treatment Market, by Drug Class, 2022 & 2032 (USD Million)
- Figure 8 Market by Route of Administration
- Figure 9 Global Trachoma Treatment Market, by Route of Administration, 2022 & 2032 (USD Million)
- Figure 10 Trachoma Treatment Market Assessment, By Geography, 2019-2032 (USD Million)
- Figure 11 Strategic Analysis - Trachoma Treatment Market
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.